Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Atrial Fibrillation

• Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
• DUTCH Weight Control in Atrial Fibrillation Study
• Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease
• Effect of Alpha-Lipoic Acid Supplementation on the Incidence of Postoperative Atrial Fibrillation in Cardiac Surgery Patients
• Single Dose Flecainide for Early Sinus Rhythm Conversion of Perioperative Atrial Fibrillation After Noncardiac Surgery
• Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)
• Empagliflozin to Prevent Post-Operative Atrial Fibrillation
• Silymarin for the Prevention of Atrial Fibrillation After Cardiac Surgery
• Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation
• Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
• Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention
• Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
• The Impact of Oral Vitamin C in Prevention for Post Operative Atrial Fibrillation (POAF) in Coronary Artery Bypass Surgery (CABG) Patients
• Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
• Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
• Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF
• LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.
• COnventional vs. Optimised PERiprocedural Analgosedation vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA)
• Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
• Remimazolam for Postoperative Atrial Fibrillation
• Colchicine After Electrocardioversion for Atrial Fibrillation
• METFORMIN FOR ATRIAL FIBRILLATION
• Comparison of Patients' Satisfaction Between Dexmedetomidine and Remimazolam Anesthesia in Patients With Atrial Fibrillation Undergoing Catheter Ablation
• SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
• Ondansetron for the Management of Atrial Fibrillation
• Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension
• Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
• Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
• Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure
• Perioperative Management of Factor Xa Inhibitors
• EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment
• AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation
• Exploratory Observation of Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With High Risk of Bleeding
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
• The Effect of Preoperative SGB on POAF After VATS
• Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor
• Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery
• Clinical Efficacy and Safety of Antazoline in Comparison to Propafenone in Conversion of Paroxysmal Atrial Fibrillation to Sinus Rhythm - a Single Center, Randomized, Double-blinded Study (the AnPro Study).
• Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC)
• Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response
• Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
• Combined Use of Dexmedetomidine and Hydrocortisone to Prevent New Onset AF After CABG Surgery
• Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion
• Peri-Operative Magnesium Infusion to Prevent Atrial Fibrillation Evaluated.
• Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate
• Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients
• Stellate Ganglion to Prevent Atrial Fibrillation
• Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
• Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia
• Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
• Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker
• Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
• Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation
• The Impact of "First-Line" Rhythm Therapy on AF Progression
• Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting
• Pilot RCT of Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma
• Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation
• Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation and Atrial Flutter Who Underwent Catheter Ablation
• Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter
• A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With No
• Comparison of Remimazolam With Flumazenil vs. Propofol During RFCA for Atrial Fibrillation
• Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation
• A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation
• LAAO Versus NOAC in Patients With AF and PCI
• The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation
• The Effect of Intra Operative Dexmedetomidine in Prevention of Early Postoperative Atrial Fibrillation
• Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
• Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery
• RiLuzole to Reduce Atrial FIbrillatiON A Prospective, Double-Blind, Randomized, Placebo-Controlled Study Using Holter Monitoring
• MAGNAM Trial, Magnesium Versus Amiodarone in AF in Critical Care
• Henagliflozin in Patients With Atrial Fibrillation
• Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia
• Semaglutide to Reduce Atrial Fibrillation Burden
• Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
• Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery
• Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments
• Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
• Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation
• Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
• Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement
• Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins
• Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
• The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
• Repeated Amiodarone Dosing In Cardiac surgicaL Procedures
• Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
• Study of Apixaban in Patients Receiving Hemodiafiltration
• Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation
• EMOTIon and COgNitive Function After Atrial Fibrillation Catheter Ablation vs. Medical Therapy(EMOTICON Trial)
• A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF
• Post-Ablation Pericarditis Reduction Study
• Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
• Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
• AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
• Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
• Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.
• The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers
• Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
• Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients
• Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF
• Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence
• Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
• Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
• Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation
• Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI
• Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF
• A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)
• COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
• Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation
• First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation
• Prevention of Atrial Fibrillation by Low-dose Landiolol Administration After Cardiac Surgery
• Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
• Empagliflozin and Atrial Fibrillation Treatment
• A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation
• A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
• Rate Control in Patients With Atrial Fibrillation
• Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AF
• Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
• RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
• Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy
• Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery
• ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2
• The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
• What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
• 2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation
• AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)
• CHAMPION-AF Clinical Trial
• Prophylaxis for Patients at Risk to Eliminate Post-operative Atrial Fibrillation
• Cardiovascular Risk Reduction in Atrial Fibrillation Trial
• Mineralocorticoid Antagonism to Stop Progression of Atrial Fibrillation (MONITOR-AF) Study
• Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction
• Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
• Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents
• Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT)
• Amplatzer Amulet LAAO vs. NOAC
• COlchicine in Cardiac Surgery
• Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac Surgery
• Clinical Usefulness of Virtual Antiarrhythmic Drug Test in Patients With Recurred AF After Catheter Ablation(CUVIA-AF3)
• Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation)
• Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation With Stabilized Coronary Artery Disease
• Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation
• Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion
• Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot)
• Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
• A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers
• Atrial Fibrillation Recurrence Following Cardioversion: the Role of Clinical Factors and Alpha Defensin Levels
• Anticoagulation on Demand in Paroxysmal Atrial Fibrillation After Percutaneous Coronary Intervention
• Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter
• Safety and Efficacy of Edoxaban in Thoracoscopic Ablation
• Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
• Rapid Atrial Fibrillation Treatment Strategy
• Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
• AntiCoagulants and COGnition
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
• Dabigatran for Mitral Stenosis Atrial Fibrillation
• Controlling Rapid Atrial Fibrillation With Dexmedetomidine
• First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)
• DUAL Antithrombotic Therapy in Patients With AF and ACS
• PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
• Iron in Patients With Cardiovascular Disease
• Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
• Ivabradine for Rate Control in Permanent Atrial Fibrillation
• Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study)
• Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative Atrial Fibrillation After Noncardiac Surgery
• A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation
• EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
• Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation
• RIvoraxaban in Mitral Stenosis
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
• Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
• Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG
• Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
• Liraglutide Effect in Atrial Fibrillation
• The Deep Sedation for Ablation Study
• Resolution of Thrombi in Left Atrial Appendage With Edoxaban
• Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation
• Imaging of LAA Thrombosis
• Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation
• Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation
• Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prophylaxis Against Atrial Fibrillation After on Pump Coronary Artery Bypass Surgery
• Oral Anticoagulation in Hemodialysis
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
• A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation
• Effect of ARNI in Patients With Persistent AF and Enlarged Left Atrium After Catheter Ablation
• RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD
• Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open-chest Cardiac Surgery (NOVA)
• Landiolol in Postoperative Atrial Fibrillation
• OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial
• Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation
• Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease
• Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies
• IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).
• CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial
• Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response
• Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)
• Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
• Post-operative Corticosteroid Treatment After Mitral Valve Surgery
• Propafenone in the Treatment of Atrial Fibrillation
• Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation
• Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)
• Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence
• Anticoagulation After RFCA
• Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.
• TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery
• INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)
• Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).
• Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.
• Dabigatran Versus Warfarin With NVAF Who Undergo PCI
• Half-normal Saline in Atrial Fibrillation Ablation
• Lixiana Acute Stroke Evaluation Registry
• Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)
• A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation
• Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
• Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
• Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
• Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drugs in Persistent Atrial Fibrillation
• Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation
• Time-dependent Amiodarone Treatment in Atrial Fibrillation
• Long Term Evaluation and Management of Atrial Fibrillation in Pacemaker Patients
• Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation
• A Phase 1 Study of HBI-3000
• ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
• This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding
• The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention
• Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)
• Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure
• Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation
• D-dimer to Guide Anticoagulation Therapy in Patients With Atrial Fibrillation
• Avoiding Anticoagulation After IntraCerebral Haemorrhage
• Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)
• Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients
• Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
• Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants
• Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation
• Start or STop Anticoagulants Randomised Trial (SoSTART)
• Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
• Vitamin C in Atrial Fibrillation Ablation
• Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
• Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
• The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
• Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing
• STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
• Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation
• Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis
• Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation
• Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation
• Effect of Colchicine on the Incidence of Atrial Fibrillation in Open Heart Surgery Patients
• Preoperative Carbohydrate Load and Intraoperative w3-PUFA in CAGB Surgery
• Effect of Low Dose ColchiciNe on the InciDence of POAF
• Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents
• NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH
• Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
• Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease
• The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation
• Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban
• Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
• Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists
• Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
• Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN)
• Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation
• Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
• Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation
• Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
• Diltiazem vs. Metoprolol in the Acute Management of AF in Patients With HFrEF
• ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)
• Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
• Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
• Metformin as an Upstream Therapy in Atrial Fibrillation
• The Effect of Magnesium Therapy to Prevent Post-operative Atrial Fibrillation After Cardiac Surgery in Adults
• Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy
• Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF.
• Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
• Use of Public Health Surveillance Models in the French National Health System Database
• Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
• Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study
• Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
• Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
• Patient Convenience Study- NIS RELATE
• Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation
• Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage
• Early Aggressive Invasive Intervention for Atrial Fibrillation
• Apixaban Dose Reduction in Patients With Elevated Drug Levels
• Study of DU-176b Aged 80 Years or Older
• Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients
• A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation
• Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study
• Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy
• Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S
• Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation
• High Dose Vitamin C in Cardiac Surgery Patients
• Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants
• Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
• Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation
• Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo.
• Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France
• New Formulations of Propafenone to Treat Atrial Fibrillation
• AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)
• Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.
• Rate Control in Atrial Fibrillation II
• Real-world Comparative Effectiveness of Rivaroxaban Versus VKA
• Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist
• Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist
• Catheter Ablation vs. Medical Therapy in Congested Hearts With AF
• Spironolactone in Atrial Fibrillation
• Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock
• Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation
• Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA
• The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients
• Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study
• APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study
• What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
• Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial Fibrillation
• Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan
• Burden of Illness in Atrial Fibrillation
• Atrial Fibrillation Patient Preference Study
• Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies
• Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
• Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease
• Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
• Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon
• COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF
• Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
• EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation
• An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant The
• Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban
• Pleotropic Effect of New Oral Anticoagulants
• Bioequivalence Study of Rivaroxaban
• Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects
• Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation
• Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation
• Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery
• A Prospective Study of Different Digoxin Treatment Regimens in Egyptian Hospital
• Real-Life Evidence on Stroke Prevention in SPAF
• LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke
• An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
• Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation
• Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm
• Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study
• Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation
• Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the H
• Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)
• Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103
• A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF
• Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF
• The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
• Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)
• Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
• AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation
• Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
• Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran
• Vitamin K Supplementation in Patients on Hemodialysis
• Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk
• RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial
• Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)
• Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure
• Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
• Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
• Colchicine in Atrial Fibrillation to Prevent Stroke
• Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention
• INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)
• Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain
• Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF
• Rate Control in Atrial Fibrillation
• Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department
• The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
• Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)
• Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
• START-Register: Survey on Anticoagulated Patients Register
• Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
• Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs
• Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
• Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation
• Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
• Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
• Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
• Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke
• A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
• Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
• Early Post-marketing Study of Eliquis (Apixaban)
• Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa
• Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation
• Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure
• Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
• Acupuncture in Persistent Atrial Fibrillation
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
• Cardiac Surgery and the Risk of Atrial Fibrillation: an Intervention Trial Evaluating Melatonin
• A Study of Caffeine on Cardiac Arrhythmias
• BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies
• Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
• Triple vs. Dual Therapy
• Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)
• Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
• A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
• Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation
• Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
• Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
• The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage
• Therapy of Atrial Flutter by Afib Ablation
• Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
• Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)
• Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control
• Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation
• Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
• Atrial Fibrillation and Neuropathic Pain After Thoracotomy and Continuous Application of Magnesium Sulphate.
• Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation
• Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
• Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
• Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation
• Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo
• The HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) Study
• Cognitive Impairment Related to Atrial Fibrillation Prevention Trial
• Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation
• Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
• Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
• Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study
• Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study
• Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism
• Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
• Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study
• Atrial Fibrillation and By-pass Surgery
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
• Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation
• Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial)
• Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation
• Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter
• Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation
• Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
• Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function
• The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure
• Eliquis Regulatory Post Marketing Surveillance
• Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)
• Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
• Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment
• The Study of Warfarin Maintenance Dose in Chinese Patients
• Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism
• Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study
• Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction
• Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter
• Efficacy and Safety Study of F373280
• A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
• Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter
• Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF
• Antithrombotic Triple Therapy in Humans
• Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication
• Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
• Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region
• Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function
• Moxonidine for Prevention of Post-ablation AFib Recurrences
• Statin Therapy In Atrial Refractoriness and Reperfusion Injury
• Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation
• SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea
• Colchicine and CRP in Atrial Fibrillation and AF Ablation
• Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia
• ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)
• Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study
• A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy
• Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
• Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation
• Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation
• Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation
• Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients
• A Comparison of the Drug Therapy Versus Re-Ablation
• Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
• Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation
• Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm
• Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
• Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
• Rate Control in Atrial Fibrillation
• Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology or Drug Therapy for Patients With AF Requiring Mitral Valve Surgery
• A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.
• Vernakalant Versus Flecainide: Atrial Contractility
• A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)
• Carvedilol for Prevention of Paroxysmal Atrial Fibrillation
• Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation
• Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
• Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial
• Early Versus Late DC-cardioversion of Persistent Atrial Fibrillation. Effect on Atrial Remodeling,Inflammatory and Neurohumoral Markers and Recurrence of Atrial Fibrillation
• Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
• Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation
• Vitamin C and Atrial Fibrillation After Cardiac Surgery
• Statin Therapy In Cardiac Surgery
• Atrial Fibrillation Progression Trial
• Safety of Amiodarone and Ranolazine Together in Patients With Angina
• Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery
• COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)
• Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation
• Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion
• Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation
• Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF)
• Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation
• Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation
• A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation
• Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial Fibrillation
• Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation
• Kansai Plus Atrial Fibrillation Trial
• DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation
• Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit
• Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation
• Substrate Ablation and Remodelling in Non-paroxysmal Atrial Fibrillation (AF)
• The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation
• Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF
• Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery
• Catheter Ablation Versus Medical Treatment of AF in Heart Failure
• Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)
• Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
• Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden
• Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
• Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion
• Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist
• Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China
• Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
• PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer
• Pulmonary Vein Ablation Versus Amiodarone in the Elderly
• Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus Rhythm
• Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation
• Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer
• Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation
• Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)
• Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter
• PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin
• Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation
• Effect of BMS-914392 on Pharmacokinetics of Metoprolol
• Effect of Diltiazem on Pharmacokinetics of BMS-914392
• Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes
• ST-segment Elevation as an AF Endophenotype
• Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation
• Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement
• n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation
• Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
• SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI
• Spanish Atrial Fibrillation And Resynchronization Study
• Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting
• A Study of the Efficacy and Safety of Vernakalant Hydrochloride (MK-6621) in Patients With Atrial Fibrillation (MK-6621-010 AM4)
• Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation
• Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery
• Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
• Postoperative New-onset Atrial Fibrillation in Cardiac Surgery: DECS-PNAF Project
• Anticoagulation in Stent Intervention
• Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation
• A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin
• Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers
• Vitamin C for Prophylaxis of Post-operative Atrial Fibrillation in On-pump Cardiac Surgery Procedures
• Drug Interaction Between Paracetamol and Warfarin
• Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation
• Phase 2 Study of Oral K201 for Prevention of AF Recurrence
• Magnesium Sulphate for Treatment of New Onset Atrial Fibrillation in Medical Intensive Care Unit Patient
• Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)
• Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)
• Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation
• Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
• A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045)
• BAY59-7939 Japanese in Atrial Fibrillation (2nd)
• BAY59-7939 in Atrial Fibrillation Once Daily (OD)
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
• Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation
• Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation
• Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery
• Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation
• Totally Endoscopic Ablation of Atrial Fibrillation
• A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
• Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation
• Warfarin Patient Self-Monitoring
• Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305
• Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
• Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
• Catheter Ablation Versus Medical Rate Control for Atrial Fibrillation in Patients With Heart Failure
• Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation
• Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery
• Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation
• Pulmonary Vein Isolation Outcomes With Fish Oils
• Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery
• Low Dose of Diltiazem for Rate Control of Atrial Fibrillation
• Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation
• The Effect of Short Term Amiodarone Treatment After Catheter Ablation for Atrial Fibrillation
• Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy
• Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
• RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
• Corticosteroid Pulse After Ablation
• DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation
• Effects of Fish Oil on Post Ablation Arrhythmias
• A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation
• Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)
• Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery
• Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
• BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status
• Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation
• Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
• Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin
• Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation
• Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
• Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD
• Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer
• Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation
• Safety Study of Tecadenoson to Treat Atrial Fibrillation
• An Interaction Study With Digoxin and AZD1305
• Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
• European Study of Dronedarone in Atrial Fibrillation
• N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure
• Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
• Spironolactone for Paroxysmal Atrial Fibrillation
• Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
• A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation
• Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft
• The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome
• EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion
• Long-term Safety in Atrial Fibrillation Patients
• Explorative Study of AZD1305 in Atrial Fibrillation Patients
• Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation
• Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)
• Irbesartan and Adhesion Molecules in AF
• Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery
• Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid
• Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation
• Ibutilide Administration During Pulmonary Vein Ablation
• AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study
• Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon
• Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
• The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation
• Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
• Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.
• Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
• Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
• A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
• Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
• A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation
• Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation
• Tailored Treatment of Permanent Atrial Fibrillation
• A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation
• Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
• Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
• Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
• Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting
• Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs
• Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
• Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension
• Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients
• Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
• Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
• Corticosteroids for the Prevention of Atrial Fibrillation After Cardiac Surgery
• Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
• Odiparcil QT Definitive Study
• Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation
• Prevention of Atrial Fibrillation Following Esophagectomy
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
• Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.
• A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation
• An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
• Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
• Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
• Continuous Versus Episodic Amiodarone Treatment for the Prevention of Permanent Atrial Fibrillation
• High Intensity Focused Ultrasound (HIFU) Ablation System Study
• First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)
• Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers
• GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
• Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
• Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)
• The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)
• A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)
• A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
• Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins
• RATe Control in Atrial Fibrillation
• Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection
• Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis
• Curing Atrial Fibrillation in Heart Failure
• Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery
• Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)
• Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)
• Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation
• Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation
• Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence
• Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
• EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)
• American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm
• Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation
• Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)
• Amiodarone to Prevent Post-Operative Arrhythmias
• Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
• Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)
• Odiparcil For The Prevention Of Venous Thromboembolism
• S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation
• Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)
• Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
• Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter
• Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr
• Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.
• Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia
• Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion
• Safety and Efficacy of CryoCor™ Cryoablation for PAF
• CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation
• Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers
• Flecainide-Short Long Study (Flec-SL)
• Long Term Open Follow-up With H376/95 vs. Warfarin
• Statin and PAF in Patients With Pacemaker
• Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery
• To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation
• A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation
• Atrial Fibrillation Feasibility Certoparin Trial - AFFECT
• Genetic Determinants of Warfarin Anticoagulation Effect
• Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048
• Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)
• FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)
• Candesartan in the Prevention of Relapsing Atrial Fibrillation
• WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation
• Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery
• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects
• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
• Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery
• NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
• Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter
• Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
• Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)
• Prevention Of Recurrence Of Atrial Fibrillation
• Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation
• Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
• Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
• Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.
• Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm
• Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
• Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)